Market News

Costco topped quarterly earnings and revenue expectations, even as sales trends at the membership club slowed.

Whether or not all of this is an illusion or Argentina's version of extravagant far-right outsider ala Donald Trump and Jair Bolsonaro remains to be seen.

The S&P 500 finished higher--barely--after falling earlier in the day; the Dow slipped.

New mixed-reality headset and AI tools will keep costs high--raising pressure for ad growth.

Traders have unique needs and opportunities in tax planning. Get organized well before the year-end so you don't miss out.

The idea of early retirement is undoubtedly attractive and the desire to retire early from the job market may be widespread.

It is important to note that the income tax department may scrutinize your HRA claim if you are claiming it for multiple properties

Sebi's interventions, technological advances have revolutionized the mutual fund landscape

The shutdown is among a "long list" of headwinds for the wobbling economy, according to Fed chief Jerome Powell.

We believe that Zoetis stock (NYSE: ZTS), an animal health company, is a better pick than Keurig Dr Pepper stock (NASDAQ: KDP), given its better prospects.

If there's one thing we need to remember when we buy high-yield closed-end funds (CEFs), it's this: always demand a discount.

AI darling, Nvidia, is down almost 17% from its high of nearly $503/share.

Returning to the pre-inflation shock level of over $80 means that BMY stock will have to gain more than 35% from here, and we think it will likely materialize over time.

Technology companies and developers have been rushing to deploy generative artificial intelligence into their applications following the success of OpenAI's ChatGPT ch...

JPMorgan Chase has already paid out $290 million this year to Epstein's victims, in a class action civil suit that was filed along similar lines

Thin profit margins and growing competition don't support monopolist charge.

Looking at stock returns, both have underperformed vis-a-vis broader markets amid slowing economic growth.

The beloved retailer is doing just fine but appears to be taking a cautious view on consumers.

Embracing fractional thinking might be straightforward in arithmetic but poses regulatory challenges in company law and taxation. Nonetheless, adopting this approach could level the playing field for India's retail inves...

Amgen has a couple of shots on goal to break into one of the biggest markets the pharmaceutical industry has ever seen.

The stock has been impacted by the Macau operations, which saw business largely collapse over 2021 and 2022, due to China's stringent Covid-19 restrictions which hurt ...

The South Africa-focused company announced a 14% rise in first-half sales, as economic conditions in its core market improved.